| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | | |
Result : Searchterm 'brain' found in 3 terms [] and 54 definitions []
| previous 46 - 50 (of 57) nextResult Pages : [1] [2 3 4 5 6 7 8 9 10 11 12] | | | | Searchterm 'brain' was also found in the following services: | | | | |
| | |
| |
|
An image in which the signal from two spectral components (such as fat and water) is 180° out of phase and leads to destructive interference in a voxel.
Since fat precesses slower than water, based on their chemical shift, their signals will decay and precess in the transverse plane at different frequencies. When the phase of the TE becomes opposed (180°), their combined signal intensities subtract with each other in the same voxel, producing a signal void or dark band at the fat/water interface of the tissues being examined.
Opposed phase gradient echo imaging for the abdomen is a lipid-type tissue sensitive sequence particularly for the liver and adrenal glands, which puts a signal intensity around abnormal water-based tissues or lesions that are fatty.
Due to the increased sensitivity of opposed phase, the tissue visualization increases the lesion-to-liver contrast and exhibits more signal intensity loss in tissues containing small amounts of lipids compared to a spin echo T1 with fat suppression.
Using an opposed phase gradient echo also provides the ability to differentiate various pathologies in the brain, including lipids, methaemoglobin, protein, calcifications and melanin.
See also Out of Phase, and Dixon. | | | | | | | | | | | Further Reading: | News & More:
|
|
| |
| | | | | |
| |
|
OptiMARK® is a formulation of a nonionic gadolinium chelate of diethylenetriamine pentaacetic acid bismethoxyethylamide ( gadoversetamide), for use as a paramagnetic MRI contrast agent.
OptiMARK® ( gadoversetamide injection) is to be administered by intravenous injection.
OptiMARK® is indicated for MRI diagnostic procedures to provide increased enhancement and visualization of lesions of the brain, spine and liver, including tumors. WARNING: NEPHROGENIC SYSTEMIC FIBROSIS
Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis (NSF) in patients with acute or chronic severe renal insufficiency (glomerular filtration rate less than 30 mL/min/1.73m 2), or acute renal insufficiency of any severity due to the hepato-renal syndrome or in the perioperative liver transplantation period.
Drug Information and Specification T1, Predominantly positive enhancement PHARMACOKINETIC Intravascular, extracellular DOSAGE 0.1 mmol/kg / 0.2 mL/kg PREPARATION Finished product INDICATION Neuro/whole body PRESENTATION Vials of 5, 10, 15, 20, 50 mL and
Pre-filled syringes of 10, 15, 20 and 30 mL DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Distribution Information TERRITORY TRADE NAME DEVELOPMENT STAGE DISTRIBUTOR Australia OptiMARK® for sale | | | | • View the DATABASE results for 'OptiMARK®' (5).
| | | | Further Reading: | | Basics:
|
|
News & More:
| |
| |
| | | | | |
| |
|
Any molecule used to measure organ perfusion in conjunction with imaging. Characteristics of good perfusion agents:
•
to be admitted by the perfused tissue in proportion to perfusion,
•
to remain strictly intravascular, or
•
diffuse freely throughout the tissue of interest.
Perfusion agents used in MRI are small Gd-chelates (they do not cross blood brain barrier, but extravasate quickly into extracellular space in other organs) and SPIOS. | | | | • View the NEWS results for 'Perfusion Agents' (3).
| | | | Further Reading: | Basics:
|
|
| |
| | | Searchterm 'brain' was also found in the following services: | | | | |
| | |
| |
|
| | | | | Further Reading: | Basics:
|
|
News & More:
| |
| |
| | | | | |
| |
|
| | | | | | • View the DATABASE results for 'Postprocessing' (11).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
| |
| | | | |
| | | |
|
| |
| Look Ups |
| |